REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Sunho Pharma Europe Sp. z o.o. (Poland)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Secondary Activities: Pharmaceutical and Medicine Manufacturing | Merchant Wholesalers, Durable Goods | Real Estate | Rental and Leasing Services | Legal Services | Accounting, Tax Preparation, Bookkeeping, and Payroll Services | All Other Miscellaneous Ambulatory Health Care Services | Other Personal Care Services
Full name: Sunho Pharma Europe Sp. z o.o. Profile Updated: May 01, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Sunho Pharma Europe Sp. z o.o. is based in Poland, with the head office in Warsaw. The enterprise operates in the Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) industry. The enterprise was incorporated on October 21, 2019. Its total assets decreased by 43.74% over the same period.

Headquarters
Ul. Dluga 29
Warsaw; Mazowieckie; Postal Code: 00-238

Contact Details: Purchase the Sunho Pharma Europe Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Sunho Pharma Europe Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Sunho Pharma Europe Sp. z o.o. report to view the information.
Incorporation Date:
October 21, 2019
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Sunho Pharma Europe Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
-165.41%▼
Net Profit (Loss) for the Period
-165.41%▼
Total assets
-43.74%▼
Total equity
-27.15%▼
Return on Equity (ROE)
11.12%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo